A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer

Proctor et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d77ff8b843b2be99490176 — DOI: https://doi.org/10.1038/bjc.2012.292

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study· 2011 · 743 citations
2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008· 2010 · 21,404 citations
3. Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer· 2011 · 330 citations
4. Use of Inflammatory Markers to Guide Cancer Treatment· 2011 · 87 citations
5. High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy· 2010 · 319 citations